Minicircle

Based in the United States, Minicircle is a startup. Brouky classifies it under Healthcare & Life Sciences.

Minicircle develops non-viral, reversible plasmid gene therapies, such as follistatin, administered via subcutaneous injection at licensed international partner clinics to support muscle mass, body composition, and reduce epigenetic age; these therapies are investigational and offered under regulatory frameworks outside the US.